Understanding the genetic factors behind type 2 diabetes and finding new treatment targets
Bridging the gap between type 2 diabetes GWAS and therapeutic targets
This study is looking at how certain genes might contribute to type 2 diabetes, with the goal of finding new ways to help manage the condition better for people living with it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10886729 on NIH RePORTER |
What this research studies
This research investigates the genetic components of type 2 diabetes (T2D) by identifying specific genetic variants and their roles in the disease. It employs a multi-disciplinary approach, utilizing functional genomics to analyze how these genetic factors affect insulin resistance and secretion in various tissues, including the liver, muscle, and adipose tissue. By understanding the mechanisms behind T2D risk, the research aims to validate potential drug targets and develop new therapeutic strategies that could improve treatment options for patients. Patients may benefit from insights gained through this research that could lead to more personalized and effective diabetes management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 2 diabetes, particularly those with a family history of the condition or those who have not responded well to existing treatments.
Not a fit: Patients with type 1 diabetes or those whose diabetes is not primarily influenced by genetic factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve treatment outcomes for patients with type 2 diabetes.
How similar studies have performed: Previous research has shown success in identifying genetic factors associated with type 2 diabetes, suggesting that this approach has the potential for meaningful advancements.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Mohlke, Karen L. — Univ of North Carolina Chapel Hill
- Study coordinator: Mohlke, Karen L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.